Golden Seeds

In 2004, Golden Seeds was established to create an environment where women entrepreneurs would have the opportunity to be seriously considered for capital investment and angels could gain access to invest in these innovative companies. Today, Golden Seeds is one of the largest angel investor groups in the United States, with a proven track record of investing in women-led companies across technology, health care, and consumer sectors. At the time of our founding, women were starting nearly 25% of all new companies, yet women-led companies were only 3% of companies receiving start-up capital. Investors came together to support the innovation of companies led by women and were able to present opportunities to invest in these companies. These investors, known as “angels”, developed a membership network investing directly and through funds that have become the hallmark of Golden Seeds. Requirements for Golden Seeds Funding Golden Seeds accepts applications only from women-led companies domiciled in the U.S. Eligible companies must have at least one woman in an operating C-suite role. While many have a female founder or CEO, we also consider companies with women in other executive positions. When evaluating leadership, we consider: ▪ Does the female executive have power and influence in the company? ▪ Does she own a “fair” amount of company equity, given her role and the stage of the company? Golden Seeds typically invests in companies within the B2B & B2C technologies, health care, and consumer products or services industries. What We Look For ▪ A capable management team with domain expertise ▪ A scalable business model ▪ An addressable market of at least $500 million ▪ Limited capital expenditure requirements ▪ Opportunities that can be accelerated with support from our investors ▪ A product or service in beta (versus alpha) stage of development that has been created with input from clients or potential clients ▪ “Proof of concept” revenue or significant pilots, except for health care bio/pharma, diagnostics, and devices companies ▪ A plausible exit strategy within 5-8 years ▪ Valuation at first funding is typically below $10 million ▪ Typically seeking first-round of funding of $250,000-$2,000,000